VirTra customers may notice their simulation training accessories include a small patent number and information printed on the device. This is because VirTra has gone through great lengths to patent-protect many of our training accessories.

After all, VirTra helped develop the use of force training simulation industry, shaping it into what it is today. We are proud of the work we have done, the miles we have paved and the technology that has allowed us to accomplish this feat.

Since we have worked so hard to make simulation training so state-of-the-art, realistic and valuable, VirTra decided to patent protect our products to ensure our training “secret sauce” remains with us.

VirTra’s patents currently apply to three training accessories: the Tetherless Drop-In Recoil Kits, Threat-Fire® and Axon TASER® training cartridges—though more accessories may be added in the future.

Patented Simulation Products

Tetherless Drop-In Recoil Kits—Personal duty pistols and rifles can easily be converted into simulation-ready weapons with no permanent modification required. Rifle kits support semi- and full-auto fire, while pistol kits operate at the correct cyclical rate.
Threat-Fire®— The Threat-Fire accessory enhances training by bringing real-life consequences into the simulation. This product delivers an electric impulse that simulates consequence actions, including: gunfire, explosions and dog attacks.
TASER® training cartridges—Real Axon X2 and X26P TASER®s are outfitted with VirTra’s training cartridges, allowing them to function in a simulator. Upon deploying, characters on screen react accordingly and realistically.

The entire list of patent products and numbers can be found here: VirTra’s Patent Page.

For more information on VirTra’s Patented Products and how these accessories can further increase your training simulator’s abilities, contact a VirTra representative.

*AXON ,TASER, X2 and X26P are registered trademarks of AXON ENTERPRISE, INC which can be referenced at

TEMPE, Ariz. — October 31, 2019 — VirTra, Inc. (NASDAQ: VTSI), a global provider of training simulators for the law enforcement, military, educational and commercial markets, today announced that the United States Patent and Trademark Office has issued the company two new patents: patent 10,438,503, which relates to VirTra’s TASER® cartridge kits, and patent 10,436,539, which relates to mechanical malfunction of real firearms used in simulation training.

Based on the parameters of patent 10,438,503, VirTra is the only company in the United States that can produce or sell a specially triggered training cartridge for the TASER line of products by Axon, the global leader in connected public safety technologies. The patent covers VirTra’s proprietary method of reliably triggering the training device based on the unique acoustic sound produced by a TASER Conducted Energy Weapon’s (CEW) electrical arc. This innovation allows trainees to deploy the cartridges from a real TASER CEW during simulation training and avoid high-voltage feedback. It also allows trainees to practice with a TASER CEW’s “ARC” and/or “Re-ARC” functions, which increases the realism of each training session. By using a live CEW while training in VirTra’s simulators, trainees are able to improve their technique and develop proper habits that carry into real world situations. The patent applies to both legacy units and the latest multi-cartridge systems used for the TASER X2 and TASER 7 weapons.

“TASER CEWs have been classified as ‘less-lethal’ devices, and as such, require the same type of high quality, judgmental use-of-force simulation training as lethal devices like firearms,” said Lon Bartel Director of Training and Curriculum at VirTra. “By combining live TASER CEW and VirTra training cartridges with VirTra’s simulators and library of content, trainees have an opportunity to develop critical decision-making skills when under stress as well as further develop safe weapon handling by practicing the removal and replacement of cartridges during simulations that escalate.”

Based on the parameters of patent 10,436,539, VirTra is the only company in the United States that can produce or sell a specially designed kit that affordably converts a live firearm into a safe and reliable training tool that can simulate mechanical malfunction and therefore increase realism. This patent addresses the growing need to safely, affordably, and accurately reproduce the intricacies of real firearms for training purposes. Patent 10,436,539 expands VirTra’s growing library of intellectual property related to affordably converting real firearms (whether pistol or rifle) into suitable training tools that can be used in realistic simulation training without the expense or hassle of modifying the original firearm.

Bob Ferris, VirTra Chairman and CEO, added, “These new patents are the latest progression in the strategy we outlined at the beginning of the year to bolster our technological capabilities. These patents not only expand our competitive moat by protecting important simulated weapon technology, but they also help ensure that VirTra remains an industry leader and continues to offer the highest quality judgmental use-of-force simulation training available.”

About VirTra
VirTra (NASDAQ: VTSI) is a global provider of judgmental use of force training simulators, firearms training simulators and driving simulators for the law enforcement, military, educational and commercial markets. The company’s patented technologies, software, and scenarios provide intense training for de-escalation, judgmental use-of-force, marksmanship and related training that mimics real-world situations. VirTra’s mission is to save and improve lives worldwide through practical and highly-effective virtual reality and simulator technology. Learn more about the company at

About Axon
Axon (NASDAQ: AAXN) is a network of devices, apps and people that helps public safety personnel become smarter and safer. With a mission of protecting life, its technologies give customers the confidence, focus and time they need to keep their communities safe. Axon’s products impact every aspect of a public safety officer’s day-to-day experience.

Axon works hard for those who put themselves in harm’s way for the rest of the community. To date, there are more than 397,800 software seats booked on the Axon network around the world and more than 223,000 lives and countless dollars have been saved with the Axon network of devices, apps and people. Learn more at or by calling (800) 978-2737.

Facebook is a trademark of Facebook, Inc., Twitter is a trademark of Twitter, Inc., TASER 7, TASER X2, Axon and the Delta Logo are trademarks of Axon Enterprise, Inc., some of which are registered in the US and other countries. For more information, visit All rights reserved.

Follow Axon here

Forward-Looking Statements:
This news release includes certain information that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about VirTra’s beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although VirTra believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. VirTra cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof, is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.


Investor Relations Contact:
Matt Glover or Charlie Schumacher